Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/fluorouracil/methotrexate protocol

Known as: CMF Regimen, Cytoxan-Methotrexate-Fluorouracil Regimen, Cyclophosphamide/Fluorouracil/Methotrexate 
An abbreviation for a chemotherapy combination used alone or with other therapies to treat breast cancer. It is also being studied in the treatment… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMethotrexate
Breast CarcinomaDaunorubicinFluorouracilVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907
507 Background: Older women with BC are underrepresented in clinical trials. Scant data exist on the effects of adjuvant… 
2006
2006
Anthracyclines and the tailoring of treatment for early breast cancer.
Adjuvant chemotherapy and hormonal treatment have substantially reduced the risks of relapse and death that threaten a woman for… 
2004
2004
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?
The role of p53 in modulating apoptosis has suggested that it may affect efficacy of anti cancer agents. For this reason, we have… 
2000
2000
Remission Rates Following Preoperative Chemotherapy and Radiation Therapy in Patients with Breast Cancer
Purpose: To evaluate remission and breast-conservation rates after preoperative chemotherapy or chemo-radiotherapy (CT-RT… 
1993
1993
The Use of Cyclophosphamide, Methotrexate, and 5‐Fluorouracil in the Treatment of Merkel Cell Carcinoma
Five patients with advanced Merkel cell carcinoma (MCC) are described. Four patients with regional lymph node involvement and one… 
1987
1987
Chemotherapy Versus Chemoimmunotherapy (CAF v CAFVP v CMF Each t MER) for Metastatic Carcinoma of the Breast: A CALGB Study
mg/m 2 orally, days 1 through 14; doxorubicin [DOX], 25 mg/m 2 IV, days 1 and 8; 5-FU, 500 mg/m 2 IV, days I and 8), or CAFVP… 
1987
1987
Methylprednisolone for the Control of CMF‐Induced Emesis
Sixty-eight breast cancer patients eligible for outpatient adjuvant chemotherapy (CT) with cyclophosphamide, methotrexate, and… 
Review
1984
Review
1984
Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
At the annual meeting of the Danish Surgical Society in December 1975, a task force was set up to nationally coordinate the new… 
1980
1980
CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
1978
1978
Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice.
A previous report from this laboratory demonstrated that mice infected intraperitoneally with a 0--20% lethal inoculum of murine…